Cumberland Pharmaceuticals Inc.
CPIX
$4.35
-$1.01-18.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.11M | 17.96M | 17.46M | 17.34M | 18.55M |
| Total Receivables | 10.49M | 11.70M | 11.31M | 11.62M | 10.65M |
| Inventory | 4.10M | 4.00M | 4.51M | 4.30M | 4.33M |
| Prepaid Expenses | 2.18M | 2.79M | 1.95M | 2.32M | 2.68M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 31.88M | 36.45M | 35.24M | 35.58M | 36.21M |
|
|
|||||
| Total Current Assets | 31.88M | 36.45M | 35.24M | 35.58M | 36.21M |
| Net Property, Plant & Equipment | 7.48M | 6.45M | 6.52M | 6.70M | 6.89M |
| Long-term Investments | 914.00K | 914.00K | 914.00K | 914.00K | 914.00K |
| Goodwill | 914.00K | 914.00K | 914.00K | 914.00K | 914.00K |
| Total Other Intangibles | 16.99M | 17.97M | 19.42M | 20.46M | 21.52M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.68M | 13.79M | 14.66M | 14.86M | 15.98M |
| Total Assets | 69.94M | 75.58M | 76.75M | 78.52M | 81.51M |
|
|
|||||
| Total Accounts Payable | 13.93M | 13.91M | 12.06M | 12.51M | 13.08M |
| Total Accrued Expenses | -- | 9.74M | -- | -- | -- |
| Short-term Debt | -- | 5.10M | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 371.10K | 356.50K | 6.38M | 376.80K | 362.20K |
| Total Finance Division Other Current Liabilities | 11.22M | 2.51M | 12.65M | 11.87M | 12.99M |
| Total Other Current Liabilities | 11.22M | 2.51M | 12.65M | 11.87M | 12.99M |
| Total Current Liabilities | 25.52M | 31.62M | 31.09M | 24.76M | 26.43M |
|
|
|||||
| Total Current Liabilities | 25.52M | 31.62M | 31.09M | 24.76M | 26.43M |
| Long-Term Debt | 5.24M | 10.18M | 10.10M | 16.09M | 16.08M |
| Short-term Debt | -- | 5.10M | -- | -- | -- |
| Capital Leases | 4.83M | 4.94M | 5.00M | 5.10M | 5.20M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.01M | 6.30M | 6.09M | 6.54M | 6.61M |
| Total Liabilities | 41.60M | 53.04M | 52.28M | 52.49M | 54.32M |
|
|
|||||
| Common Stock & APIC | 51.37M | 46.82M | 46.84M | 46.87M | 46.92M |
| Retained Earnings | -22.71M | -23.97M | -22.06M | -20.52M | -19.43M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 28.66M | 22.85M | 24.78M | 26.35M | 27.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 28.66M | 22.85M | 24.78M | 26.35M | 27.49M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -316.40K | -307.50K | -309.70K | -316.80K | -299.80K |
| Total Equity | 28.34M | 22.55M | 24.47M | 26.03M | 27.19M |
|
|
|||||